Table 4 Common Side effects of Tolvaptan treatment
From: In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis
Dry Mouth | 22% |
Thirst | 18% |
Polyuria | 5% |
CNS myelinolysis | 0% |
Elevation of Liver Enzymes | 0% |
From: In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis
Dry Mouth | 22% |
Thirst | 18% |
Polyuria | 5% |
CNS myelinolysis | 0% |
Elevation of Liver Enzymes | 0% |